Laser heat treatment for early-returning brain cancer
Part of Cancer clinical trials.
This trial tests a minimally invasive laser procedure (LITT) to treat glioblastoma that comes back very soon after initial treatment. The goal is to see if laser heat can destroy the tumor before standard radiation and chemotherapy begin, potentially improving outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with glioblastoma (a type of brain cancer) confirmed by biopsy, with specific genetic markers
- Age 18 or older
- Good overall health and ability to care for yourself (Karnofsky score of 70 or higher)
- Able to tolerate radiation and chemotherapy treatment
- Scheduled to receive radiation and chemotherapy at University Hospital of Bern
- No blood clotting disorders (not caused by medications you take)
- Cancer is limited to one area—not spread to multiple locations in the brain or body
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special ultrasound (LIFU) can open the blood-brain barrier to help an immunotherapy drug (cetuximab) reach glioblastoma tumors better. It is for people with a specific type of glioblastoma that has not been treated yet and that has a certain protein called EGFR.
This trial tests a type of radiation therapy that uses a smaller, more focused area on the brain after surgery for glioblastoma. The goal is to see if this approach can reduce side effects while still controlling the tumor.
This trial tests a minimally invasive laser procedure combined with a new immunotherapy drug (cemiplimab) to treat glioblastoma that has returned after initial treatment. The laser heats and destroys the tumor while the immunotherapy helps your immune system fight remaining cancer cells.
This trial studies a two-step treatment for newly diagnosed high-grade glioma: first laser treatment (LITT) to target the tumor, followed by a shorter, more focused course of radiation. It may help shrink or control the tumor while limiting treatment time.
This study tests a laser ablation treatment for people whose high-grade glioma (a fast-growing brain tumor) has come back after standard therapy. The goal is to see if this minimally invasive laser procedure can help control the tumor.
This trial tests a laser treatment called LITT for low-grade glioma (a type of brain tumor) that has come back or is growing despite prior treatment. It aims to see if the laser is safe and effective in young people aged 2 to 25.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.